Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stem Cell Transplant Complications × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 9 Multiple Myeloma 3 Melanoma 3 Venous Thromboembolism 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Skin Toxicity 1 Skin Neoplasms 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Renal Insufficiency 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Polycystic Ovary Syndrome 1 Obesity 1 Neoplasms 1 Myeloproliferative Disorders 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Leukemia 1 Inflammation 1 Head and Neck Neoplasms 1

Interventions

Tablets 1 Levofloxacin 1 Fluconazole 1 Acyclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03159845 2020-01-07

ZENITH

Azienda Ospedaliero, Universitaria Pisana

Phase 2 Completed

Stem Cell Transplant Complications

Data powered by HemOnc (CC BY 4.0) Colophon ⚡